menu
    • menu

    Company profile for GelMEDIX

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GelMEDIX Inc. is an early-stage biotechnology company committed to innovating the next generation of ocular and regenerative therapies through its proprietary hydrogel platform. GelMEDIX's programs are based upon its photo crosslinked hydrogels, originally developed by Prof. Nasim Annabi (UCLA) and Prof. Reza Dana (Mass Eye and Ear, Harvard Medical School). These hydrogels uniquely enable bioadhesion, tissue regeneration, tuna...
    GelMEDIX Inc. is an early-stage biotechnology company committed to innovating the next generation of ocular and regenerative therapies through its proprietary hydrogel platform. GelMEDIX's programs are based upon its photo crosslinked hydrogels, originally developed by Prof. Nasim Annabi (UCLA) and Prof. Reza Dana (Mass Eye and Ear, Harvard Medical School). These hydrogels uniquely enable bioadhesion, tissue regeneration, tunable mechanics, and therapeutic loading across modalities from small molecules to cell and gene therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GelMEDIXUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Main St North, c/o LabCentral, Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gelmedix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gelmedix/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GelMEDIX Partners with Catalent to Vision-Restoring Cell Therapy
    GelMEDIX Partners with Catalent to Vision-Restoring Cell Therapy

    15 Mar 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/gelmedix-partners-with-catalent-to-advance-vision-restoring-cell-therapies-19352

    INDPHARMAPOST
    15 Mar 2026
    Share Share
    Catalent, Gelmedix Partner For Global iPSC Cell Therapy
    Catalent, Gelmedix Partner For Global iPSC Cell Therapy

    11 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-11/catalent-and-gelmedix-enter-global-partnership-for-the-development-and-clinical-manufacturing-of-ips

    PHARMIWEB
    11 Mar 2026
    Share Share
    Gelmedix Wraps $13M Seed Funding, Reveals Initial Partnership
    Gelmedix Wraps $13M Seed Funding, Reveals Initial Partnership

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gelmedix-completes-13-million-seed-financing-and-announces-first-partnership-302689235.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    HTL Announces Its Incubator's Equity Investment In GelMEDIX
    HTL Announces Its Incubator's Equity Investment In GelMEDIX

    10 Mar 2022

    // PRESS RELEASE

    https://htlbiotech.com/news/geimedix-investment/

    PRESS RELEASE
    10 Mar 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search